These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11824804)

  • 1. Home lactulose enema: prevention of hepatic encephalopathy at home.
    Saito T; Shinzawa H; Watanabe H; Togashi H; Kawata S
    J Gastroenterol; 2002 Jan; 37(1):68-9. PubMed ID: 11824804
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of hepatic encephalopathy: it's not lactulose.
    Shawcross DL; Jalan R
    BMJ; 2004 Jul; 329(7457):112; author reply 112. PubMed ID: 15242927
    [No Abstract]   [Full Text] [Related]  

  • 3. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactulose in the treatment of hepatic encephalopathy: new evidence for an old modality.
    Jia JD
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1262-3. PubMed ID: 22823914
    [No Abstract]   [Full Text] [Related]  

  • 5. Safe and effective administration of lactulose retention enema in the ED using specialized rectal medication administration catheter.
    Macygin KMC; Lee J; Lam A; Carlstedt R; Macy B
    Am J Emerg Med; 2018 Mar; 36(3):521-522. PubMed ID: 28811210
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of hepatic encephalopathy in acute variceal bleed: a randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Agrawal A; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2011 Jun; 26(6):996-1003. PubMed ID: 21129028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond Lactulose: Treatment Options for Hepatic Encephalopathy.
    Gastroenterol Nurs; 2019; 42(3):E3-E4. PubMed ID: 31145254
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatic encephalopathy -- preventative effects of lactulose].
    Z Gastroenterol; 2013 Aug; 51(8):708. PubMed ID: 24298621
    [No Abstract]   [Full Text] [Related]  

  • 9. Lactulose a day keeps encephalopathy at bay.
    Klinken E; MacQuillan G
    J Gastroenterol Hepatol; 2011 Jun; 26(6):939-40. PubMed ID: 21564285
    [No Abstract]   [Full Text] [Related]  

  • 10. [Old wine in new bottles: Lactulose works in hepatic encephalopathy].
    Bendtsen F
    Ugeskr Laeger; 2016 Oct; 178(42):. PubMed ID: 27745574
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 12. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Tapper EB
    JAMA Intern Med; 2015 May; 175(5):868. PubMed ID: 25938321
    [No Abstract]   [Full Text] [Related]  

  • 13. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy.
    Cutler T; Mints G
    JAMA Intern Med; 2015 May; 175(5):867-8. PubMed ID: 25938320
    [No Abstract]   [Full Text] [Related]  

  • 14. Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply.
    Rahimi RS; Cuthbert JA; Rockey DC
    JAMA Intern Med; 2015 May; 175(5):868-9. PubMed ID: 25938322
    [No Abstract]   [Full Text] [Related]  

  • 15. ACP Journal Club. Adding rifaximin to lactulose increased reversal and decreased mortality in hepatic encephalopathy.
    Kowdley KV; Burman BE
    Ann Intern Med; 2013 Oct; 159(8):JC8. PubMed ID: 24126669
    [No Abstract]   [Full Text] [Related]  

  • 16. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes.
    Rahimi RS; Brown KA; Flamm SL; Brown RS
    Am J Med; 2021 Nov; 134(11):1330-1338. PubMed ID: 34242619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to dispel myths in the treatment of hepatic encephalopathy?
    Braillon A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of rifaximin versus lactulose for reducing the recurrence of overt hepatic encephalopathy and hopitalizations in cirrhosis.
    Irimia R; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1021-7. PubMed ID: 23700882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A; Sharma BC; Sharma P; Sarin SK
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut flora and hepatic encephalopathy in patients with cirrhosis.
    Riordan SM; Williams R
    N Engl J Med; 2010 Mar; 362(12):1140-2. PubMed ID: 20335591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.